Therapeutic method for the treatment or prevention of snoring
OwnerGuy Andermanninventor
Life of this patent
Estimating the term…
Abstract
This new solution according to the invention, contains mucopolysaccharides of the glycosaminoglycane type as principle active agent, and more precisely sodic chondroitin sulphate. The excipient of this composition contains at least one mercury preserving agent, one substance with isotonic properties, and a phosphate buffer. The principle active agent may be combined with plant or mineral compounds, or with homeopathic or allopathic concentrations which synergise its therapeutic activities.
Claims10
A method of treating nonsurgery-requiring chronic snoring comprising the administration to the snorer's nasopharyngeal mucous membranes shortly prior to the snorer's retiring to sleep, of an effective amount of an aqueous buffered nasal solution consisting essentially of chrondroitin sulphate sodium salt at a concentration of from 0.1 to 10 weight percent, based on the total weight of the nasal solution.
A method of treating snoring comprising the administration to the snorer's nasopharyngeal mucous membranes, shortly prior to the snorer's retiring to sleep, of an effective amount of a nasal solution consisting essentially of an aqueous solution of from 0.1 to 10 percent by weight of chondroitin sulfate sodium salt based on the total weight of the nasal solution and a homeopathic component selected from the group consisting of allophathic plants, homeopathic plants and minerals.
A method of treating snoring comprising the administration to the snorer's nasopharyngeal mucous membranes, shortly prior to the snorer's retiring to sleep, of an effective amount of a nasal solution consisting essentially of an aqueous solution of (i) from 0.1 to 10 percent by weight of chondroitin sulphate sodium salt based on the total weight of the nasal solution, (ii) sodium chloride, (iii) a phenylmercury salt, and (iv) a phosphate buffer.
A method of treating snoring comprising the administration to the snorer's nasopharyngeal mucous membranes, shortly prior to the snorer's retiring to sleep of an effective amount of a nasal solution consisting essentially of an aqueous solution of from 0.1 to 10 percent by weight of chondroitin sulphate sodium salt based on the total weight of the nasal solution, sodium chloride, a phenylmercury salt, a phosphate buffer and a homeopathic mineral and plant mixture containing Alumina, Belladonna, Plumbum and Sambucus, the mixture being present in a concentration of 5 CH.
Dependencies are inferred from the claim text.